Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 01, 2025 08:00 ET | Source: Medidata Solutions, Inc.

Unified Data Experience from Medidata Paves Way for New Industry Standard Across Leading Biopharma Companies and Contract Research Organizations

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Medidata Clinical...
May 29, 2025 08:00 ET | Source: Medidata Solutions, Inc.

Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata...
April 06, 2022 08:30 ET | Source: Celsion Corporation

Celsion and Medidata to Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial

Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients to be presented at 2022 AACR Annual Meeting being held April 8-13 in New Orleans, LA LAWRENCEVILLE, N.J., April...
March 26, 2020 08:00 ET | Source: Celsion CORP

Celsion’s OVATION 1 Study with GEN-1 in Ovarian Cancer Shows Strong Progression-Free Survival Treatment Effect Utilizing Medidata Synthetic Control Arm

Hazard Ratio of 0.53 for PFS in the Phase I Intent-To-Treat Population Synthetic Randomization Provides Means to Evaluate Strategies to Accelerate GEN-1 Clinical Program for Newly Diagnosed Stage...
June 12, 2019 19:04 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Medidata Solutions (NASDAQ: MDSO) on Behalf of Medidata Shareholders and Encourages Medidata Investors to Contact the Firm

NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Medidata Solutions (NASDAQ: MDSO) on behalf of...